Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [562]
News [2008]
Articles [139]
Editorials [6]
Conferences [68]
elearning [20]
The essential package of palliative care
Dr Eric Krakauer - Harvard Medical School, Boston, USA
The essential package of palliative care ( Dr Eric Krakauer - Harvard Medical School, Boston, USA )
3 Feb 2023
WHO guidelines for integrating palliative care into country health systems
Dr Eric Krakauer - Harvard Medical School, Boston, USA
WHO guidelines for integrating palliative care into country health systems ( Dr Eric Krakauer - Harvard Medical School, Boston, USA )
3 Feb 2023
Women Who Conquer Cancer
Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA
Women Who Conquer Cancer ( Prof Sandra Swain - Georgetown University Medical Center, Washington DC, USA )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 6: EONS Sessions
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 6: EONS Sessions ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
The 2022 OncoAlert Colloquium Day 5: GI Oncology
Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden
The 2022 OncoAlert Colloquium Day 5: GI Oncology ( Dr Gilberto Morgan - Skåne University Hospital in Lund, Sweden )
31 Jan 2023
NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy...
Dr Thomas George - University of Florida Health Cancer Center, Gainesville, USA
NRG-GI002: A phase II clinical trial platform using total neoadjuvant therapy in locally advanced rectal cancer ( Dr Thomas George - University of Florida Health Cancer Center, Gainesville, USA )
26 Jan 2023
HER-Vaxx is safe and provides clinical benefit over standard of care chemo for...
Dr Tanuj Chawla and Dr Giovanni Selvaggi
HER-Vaxx is safe and provides clinical benefit over standard of care chemo for patients with HER2-overexpressing gastric cancer ( Dr Tanuj Chawla and Dr Giovanni Selvaggi )
25 Jan 2023
Zolbetuximab + mFOLFOX6 as 1L treatment shows significantly prolonged PFS and...
Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan
Zolbetuximab + mFOLFOX6 as 1L treatment shows significantly prolonged PFS and OS in CLDN18.2+/ HER2 mG/GEJ adenocarcinoma ( Dr Kohei Shitara - National Cancer Center Hospital East, Kashiwa, Japan )
25 Jan 2023
Kinetics of postop circulating cell-free DNA and impact on MRD detection rates...
Dr Stacey Cohen - Fred Hutchinson Cancer Center, Washington, USA
Kinetics of postop circulating cell-free DNA and impact on MRD detection rates in resected stage I-III colorectal cancer ( Dr Stacey Cohen - Fred Hutchinson Cancer Center, Washington, USA )
25 Jan 2023
OPERA: Nonoperative modality (NOM) treatments of rectal cancer do not...
Prof Arthur Sun Myint - Clatterbridge Cancer Centre, Clatterbridge, UK
OPERA: Nonoperative modality (NOM) treatments of rectal cancer do not compromise the chance of cure ( Prof Arthur Sun Myint - Clatterbridge Cancer Centre, Clatterbridge, UK )
25 Jan 2023
NIVO + chemo and NIVO + IPI continue to demonstrate clinically meaningful...
Dr Ken Kato - National Cancer Center Hospital, Tokyo, Japan
NIVO + chemo and NIVO + IPI continue to demonstrate clinically meaningful survival benefit vs chemo for advanced ESCC ( Dr Ken Kato - National Cancer Center Hospital, Tokyo, Japan )
25 Jan 2023
Epidemiology, detection, and management of NAFLD: a Latin American perspective
Dr Nahum Mendez-Sanchez - National Autonomous University of Mexico, Mexico City...
Epidemiology, detection, and management of NAFLD: a Latin American perspective ( Dr Nahum Mendez-Sanchez - National Autonomous University of Mexico, Mexico City, Mexico )
20 Dec 2022

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation